Programmes for Licensing

The MerLion pipeline is focused toward the discovery and development of novel antibiotics for conditions where there is clear unmet clinical need. The following clinical and preclinical programmes are available for licensing to parties that have the appropriate capabilities to develop them rapidly and effectively.